Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4Lymphoid 3Thoracic 1Sarcoma 1Other hematologic neoplasm 1CNS 1

Conditions

Central Nervous System Neoplasms 107Neuroblastoma 64Brain Neoplasms 64Astrocytoma 59Glioblastoma 52Oligodendroglioma 42Medulloblastoma 36Gliosarcoma 34Glioma 28Optic Nerve Glioma 20Familial ependymoma 19Choroid Plexus Neoplasms 19Sarcoma 15Rhabdoid Tumor 15Lymphoma 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Osteosarcoma 12Neoplasm Metastasis 12Ependymoma 12Meningioma 11Recurrence 10Melanoma 10Spinal Cord Neoplasms 9Leukemia 9Burkitt Lymphoma 9Testicular Neoplasms 8Ovarian Neoplasms 8Neoplasms 8Dendritic Cell Sarcoma, Interdigitating 8Wilms Tumor 7

Interventions

Watchful Waiting 1Observation 1Carvedilol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Cardiotoxicity × CNS × Clear all
NCT03418961 2025-10-08

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

SWOG Cancer Research Network

Phase 3 Recruiting
491 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡